AstraZeneca
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas – Respiratory and Autoimmunity, Cardiovascular and Metabolic Diseases, and Oncology.
See below for the Latest AstraZeneca News, Analysis, Profit Results, Share Price Information, and Commentary.
AstraZeneca HK, Lippo Healthcare partner for health innovation in GBA
AstraZeneca HK, Lippo Healthcare partner for health innovation in GBA
The collaboration will address healthcare challenges in treating chronic diseases.
Join the community
Most Read
1. Synthesys eyes 100 partners for tokenised security platform 2. Digital tools underused in Asia-Pacific energy transition — ABB 3. Over 90% of global electricity to be powered by renewables by 2050 4. Hyke to launch electric ferries in Philippines, Singapore by 2027 5. Arkora accelerates 200 MW hydro pushResource Center
Awards
Nov
18
Events
Event News
Co-Written / Partner
PT Telkomsel honoured for AI and automation breakthroughs at Indonesia Technology Excellence Awards 2025
The company set benchmarks through its 1-Click platform and the launch of the Ted, Telkomsel Enterprise Digital Account Manager.
Commentary
Fluid licence on affiliated companies: An explorative strategy to consolidate Indonesia’s telecom industry
From alps to algorithms: Why Asia must wake up to Switzerland’s Deep Tech Surge